Highly rated in
Highly rated in
Check Dr. Brian J. Heller's experience treating your condition:
About Dr. Brian J. Heller

Brian Heller is an Oncologist and a Hematologist Oncology expert in Mobile, Alabama. Heller has been practicing medicine for over 26 years and is highly rated in 12 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Stomach Cancer. He is licensed to treat patients in Louisiana and Alabama. Heller is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 8 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Brian J. Heller it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Brian J. Heller accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  UnitedHealthcare
  •  Magnolia Health

Call to see if your plan is accepted.
3 Mobile Infirmary Cir, Suite 302, Mobile, AL 36607
Other Locations
1851 N Mckenzie St, Suite 103, Foley, AL 36535
29653 Anchor Cross Blvd, Daphne, AL 36526
188 Hospital Dr, Fairhope, AL 36532
3719 Dauphin St, Mobile, AL 36608
Background & Education
Graduate Institution
Louisiana State University School Of Medicine In New Orleans, 1997
Hematology Oncology
Internal Medicine in LA
Hospital Affiliations
Ascension Providence Hospital - Southfield Campus
South Baldwin Regional Medical Center
Springhill Medical Center
Thomas Hospital
Providence Hospital
Mobile Infirmary
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Randomized Study of Erlotinib vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer
A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCL in Postmenopausal Women With Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer
View 6 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors